HuLangerin-Cre-YFP f/f mice were generated to specifically mark a subset of antigen presenting immune cells, called Langerhans cells (LCs). During histological characterization of these mice, we found that, in addition to LCs an uncharacterized cell population in the central nervous system (CNS) also expressed YFP. In this study, we found that the CNS YFP + cells were negative for microglia and astrocyte markers, but they expressed mature neuronal marker NeuN and showed neuronal localization/morphology. Thus, these mice might be used to study the ontogeny, migration and the role of a subset of CNS neurons.
Introduction
Langerhans cells (LCs) are localized to the epidermis and they constitute a subset of antigen presenting dendritic cells (DCs) (Clausen and Stoitzner, 2015) . LCs have dual origins, yolk sac and fetal liver, and they share common precursors with microglia . LCs participate in promotion of self-tolerance, anti-fungal immunity, skin immunosurveillance, and protective humoral immune responses (Kashem et al., 2017) .
Langerin is a C-type lectin receptor that was originally described as a specific marker of LCs (Valladeau et al., 2000) . Later studies have found that langerin is also expressed by other subsets of DCs (Bursch et al., 2007; Poulin et al., 2007) . Langerin is required for the formation of Birbeck granules, tennis racquet-shaped cytoplasmic organelles, which were shown to play role in HIV degradation (de Witte et al., 2007) . Langerin can recognize mannose and other sugars, but no internal signaling pathway associated with it has been described to date (Clausen and Stoitzner, 2015; Romani et al., 2010) .
Human langerin driven Cre mice were generated to selectively activate or delete genes in LCs . Interestingly the human langerin promoter in mice appears to recapitulate the human expression profile (Welty et al., 2013) . The huLangerin-Cre-YFP f/f mice were shown to permanently label the LCs in the skin, mucosal surfaces and CD103/CD11b double positive DCs in the gut lamina propria, but not other mouse DCs (Welty et al., 2013) .
In this manuscript we show that huLangerin-Cre-YFP f/f mice selectively label a subset of neurons in the CNS.
Materials and Methods

Mice
huLangerin-Cre-YFP f/f mice have been previously described .
Rosa26 fl STOP fl DTA mice on C57BL/6 background were obtained from Jackson Laboratory. All experiments were performed with newborn to 12-week-old female and male mice. Mice were housed in SPF conditions in microisolator cages and fed irradiated food and acidified water. The Baylor Institutional Care and Use Committee approved all mouse protocols.
Histology
Adult and newborn pups were euthanized and their brains (including cerebellum and olfactory bulb) and spinal cords removed. The brain hemispheres were separated using surgical blades, immersed in buffered 1% PFA and fixed overnight in 4 °C refrigerator.
After intensive washing in PBS the organ samples were infused with 15 % sucrose solution overnight and then frozen in OCT. The blocks were stored in -80 °C until use.
Eight µm thick sagittal sections were prepared using a cryostat and dried at room temperature for 30 minutes. After quick rehydration in PBS the sections were stained in humidified chambers at room temperature for one hour with the following antibodies: anti-GFP/YFP-AF488 (Rockland), anti-GFAP (GA5; ThermoFisher Scientific), and anti-NeuN (A60; Millipore-Sigma). The sections were then rinsed in PBS, mounted with Aqua-Poly/Mount solution and imaged with a Nikon Ti microscope.
Flow Cytometry
Adult mice were euthanized and their brains (including cerebellum and olfactory bulb) collected, disrupted in a glass tissue grinder using RPMI (ThermoFisher Scientific) supplemented with DNAse (0.1 mg/mL; Sigma) and Liberase TL (0.3 Wunsch units/mL; Sigma). The disrupted tissue was then incubated in a CO2 incubator at 37 °C for 1 hour, with intermittent mixing. The resulting cell suspension was filtered through 40 µm cell strainer, washed with PBS, layered on Percoll gradient (30% and 70%) and centrifuged.
The cells at the interphase of 30/70% layers were collected, washed in PBS and stained with the following antibodies from BioLegend: CD11b (M1/70), CD45.2 (104), F4/80 (BM8) and CX3CR1 (SA011F11) on ice for 30 minutes. All the flow cytometric plots presented in this manuscript were pre-gated on live (using Live/Dead stain) and singlet events. Samples were analyzed on LSRFortessa flow cytometer (BD Biosciences). Data were analyzed with FlowJo software (TreeStar).
Results
HuLangerin-Cre-YFP f/f mice harbor YFP + cells in the CNS
HuLangerin-Cre-YFP f/f mice were made to track LCs, professional antigen presenting immune cells localized to the epithelia and lymph nodes . The mice were generated using BAC transgene that contains Cre under the regulation of human langerin promoter . In these mice the human langerin promoter drives the expression of Cre Welty et al., 2013) . Histological analysis revealed YFP + cells in CNS of the huLangerin-Cre-YFP f/f mice, but not in Crelittermate controls (Fig. 1) . The YFP + cells could be found throughout the CNS with certain regions of the brain, such as the hippocampus/dentate gyrus, cortical layers V-VI and some cerebral nuclei presenting with higher densities (Fig. 1) . The YFP + cells could be readily identified in newborn pups' brain as well (histology not shown). Thus, these data suggest that the human langerin promoter becomes active sometimes during the embryogenesis, which allows the Cre-mediated recombination to take place and the YFP to be expressed.
YFP + cells are a subset of neurons
Since LCs share common precursors with microglia 2013; Hoeffel et al., 2012) , we hypothesized that the YFP + cells might be a subpopulation of microglia.
To test this, we prepared single cell suspensions from adult brains and performed flow cytometry staining with classical mouse microglia markers: CD45, CD11b, F4/80 and CX3CR1 Jung, 2013; Waisman et al., 2015) . We found that the YFP + cells showed no reactivity with any of the microglia markers tested (Fig. 2) . As next, we stained adult brain sections with astrocyte marker GFAP, and found no overlap with the YFP + cells (Fig. 3) . At last, all YFP + cells showed staining with mature neuronal marker NeuN in different parts of CNS (Fig. 4) . Thus, our data support that the YFP + cells are a subset of neurons.
Discussion
Here we show that huLangerin-Cre-YFP f/f mice that were generated to track immune cells also label a subset of neurons in the CNS. The YFP + cells were already present in the newborn's CNS. The YFP + neurons were present throughout the CNS with some regions, such as the olfactory bulb, cortical layers V and VI, hippocampal dentate gyrus, and cerebellum presenting with higher densities.
The presence of YFP + cells in the newborns' brain suggest that sometimes during the embryogenesis the human langerin promoter became active which led to Cre expression and permanent labeling of these cells with YFP. The human langerin transgenic mice appear to recapitulate the human pattern of langerin expression in the skin and the gut (Welty et al., 2013) . Whether langerin is expressed in the human brain during embryonic development or after birth remains to be determined. Based on microarray data some low levels of langerin mRNA can be detected in different parts of the adult human brain (http://portal.brain-map.org/). Langerin is a C-type lectin receptor that recognizes different sugar moieties associated with microbes, however, no signaling pathways associated with langerin have been identified to date (Valladeau et al., 2003) . The possible role if any of langerin expression in neurons remains to be determined.
The YFP + cells are present in higher densities in the areas where adult neurogenesis takes place, such as the dentate gyrus (Gage and Temple, 2013; Homem et al., 2015) .
However, to determine whether new YFP + neurons are also generated in adult brain a more careful time course analysis in combination with early neuronal markers, such as Sox2, DCX, and PSA-NCAM will be needed. The use of huLangerin-CreER T2 -YFP f/f (Bobr et al., 2012) treated with tamoxifen at different stages of embryogenesis or adult life will also help to settle this question.
It will also be important to determine the nature of these neurons. Based on their widespread distribution in the CNS it is expected that the YFP + cells to be a heterogenous population. Their heterogeneity might be due to different differentiation pathways that the YFP + precursor cells have followed or because of distinct neuronal precursors were labeled with YFP. Their presence and localization in the dentate gyrus and cerebellum suggest that at least some of these YFP + cells are granule cells. The YFP + cells in the cortical layers V and VI could contribute to cortical efferent projections to basal ganglia, brain stem and spinal cord, and to the multiform or fusiform layer, projections to the thalamus, respectively. In the spinal cord they could be interneurons and/or part of the motoneuron system. Their identity could be confirmed by breeding these mice to different neuronal cell reporter mice and with the use of cell subset specific markers. A more detailed characterization could be achieved by RNA-seq performed on flow sorted cells or on samples isolated from different parts of the CNS using laser capture microscopy.
Our preliminary efforts to delete these cells by breeding the huLangerin-Cre-YFP f/f mice to floxed "STOP" DTA mice, to gain insights into their physiological roles, remained unsuccessful. This could be due to the limitations of the Cre-lox system. It has been documented that when multiple floxed genes are combined with low Cre levels, preferential deletion of the certain targets could occur (Liu et al., 2013) . These mice efficiently deleted the LCs in the skin and lymph nodes (data not shown). However, the YFP signal levels in the neurons are at least a log magnitude lower than in the LCs (unpublished observation). These data therefore suggest that in the neurons the Cre expression might not reach a level that would aid the deletion of the STOP codons on all the alleles and that could lead to non-toxic DTA levels.
In summary, here we describe a new mouse model that could contribute to our understanding of the development of the CNS, ontogeny, neurogenesis and neuronal migration patterns. 
